These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23242962)

  • 1. Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.
    Papapetropoulos N; Papapetropoulou M; Vantarakis A
    Infection; 2013 Apr; 41(2):525-8. PubMed ID: 23242962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and antimicrobial susceptibility of Staphylococcus lugdunensis in a Greek tertiary-care hospital.
    Kachrimanidou M; Malliou P; Meletis G; Netsika F; Mavrovouniotis I; Protonotariou E; Skoura L
    New Microbiol; 2020 Jul; 43(3):133-135. PubMed ID: 32596739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin and soft tissue infections caused by Staphylococcus lugdunensis: report of 20 cases.
    Arias M; Tena D; Apellániz M; Asensio MP; Caballero P; Hernández C; Tejedor F; Bisquert J
    Scand J Infect Dis; 2010 Dec; 42(11-12):879-84. PubMed ID: 20735327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.
    Frank KL; Del Pozo JL; Patel R
    Clin Microbiol Rev; 2008 Jan; 21(1):111-33. PubMed ID: 18202439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
    Lozano-Masdemont B; Gómez-Recuero-Muñoz L; Pulido-Pérez A
    Actas Dermosifiliogr; 2015 Nov; 106(9):769-70. PubMed ID: 26076877
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.
    Farrell DJ; Mendes RE; Bensaci M
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):85-88. PubMed ID: 30314652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and microbiological properties of Staphylococcus lugdunensis skin infections.
    Zaaroura H; Geffen Y; Bergman R; Avitan-Hersh E
    J Dermatol; 2018 Aug; 45(8):994-999. PubMed ID: 29897142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Staphylococcus lugdunensis infection: report of 44 cases].
    Betrán A; Cebollada R; Lavilla MJ; Torres L
    Rev Chilena Infectol; 2022 Jun; 39(3):254-259. PubMed ID: 36156686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.
    Natsis NE; Cohen PR
    Am J Clin Dermatol; 2018 Oct; 19(5):671-677. PubMed ID: 29882122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.
    McHardy IH; Veltman J; Hindler J; Bruxvoort K; Carvalho MM; Humphries RM
    J Clin Microbiol; 2017 Feb; 55(2):585-595. PubMed ID: 27927926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of methicillin resistant
    Upreti N; Rayamajhee B; Sherchan SP; Choudhari MK; Banjara MR
    Antimicrob Resist Infect Control; 2018; 7():121. PubMed ID: 30338059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Staphylococcus lugdunensis infection: Report of thirteen cases].
    Sánchez P; Buezas V; Maestre JR
    Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):475-8. PubMed ID: 11844452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary lung abscess caused by Staphylococcus lugdunensis.
    Chou DW; Lee CT
    J Infect Chemother; 2017 Nov; 23(11):791-793. PubMed ID: 28751155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan.
    Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ
    J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of
    Hurvitz N; Cahan LOS; Gross I; Grupel D; Megged O; Pasternak Y; Temper V; Levy R; Weiser G; Hashavya S
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 34038340
    [No Abstract]   [Full Text] [Related]  

  • 16. Virulence factors among Staphylococcus lugdunensis are associated with infection sites and clonal spread.
    Giormezis N; Kolonitsiou F; Makri A; Vogiatzi A; Christofidou M; Anastassiou ED; Spiliopoulou I
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):773-8. PubMed ID: 25471196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of oxacillin-resistant Staphylococcus lugdunensis carrying staphylococcal cassette chromosome mec type V in central Taiwan.
    Yen TY; Sung YJ; Lin HC; Peng CT; Tien N; Hwang KP; Lu JJ
    J Microbiol Immunol Infect; 2016 Dec; 49(6):885-891. PubMed ID: 25648670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
    Liang M; Mansell C; Wade C; Fisher R; Devlin G
    N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infection by Staphylococcus lugdunensis: clinico-microbiologic characterization of 25 cases].
    Ros MJ; Ramírez A; Arteaga E; Alberto C; Gil J; Reina J
    Enferm Infecc Microbiol Clin; 1999 May; 17(5):223-6. PubMed ID: 10396086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options.
    Taha L; Stegger M; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1449-1455. PubMed ID: 31144243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.